Evidence map›Paper›PMID 39355768›Full record

ArticleClinical case reports2024

Triple therapy approach for treating chromoblastomycosis in a Lebanese patient.

Joe Khodeir, Paul Ohanian, Hala Abi Rached Megarbane

Abstract read
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joe KhodeirDepartment of Dermatology at Saint Georges Hospital University Medical Center, Faculty of Medicine and Medical Sciences University of Balamand Beirut Lebanon.ORCID https://orcid.org/0009-0006-7717-2646
Paul OhanianDepartment of Family Medicine at Saint Georges Hospital University Medical Center, Faculty of Medicine and Medical Sciences University of Balamand Beirut Lebanon.ORCID https://orcid.org/0009-0007-3351-5288
Hala Abi Rached MegarbaneDepartment of Dermatology at Saint Georges Hospital University Medical Center, Faculty of Medicine and Medical Sciences Saint George University of Beirut Beirut Lebanon.ORCID https://orcid.org/0009-0005-0157-9952

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromoblastomycosis, though rare in non-endemic regions like Lebanon, should be considered in patients presenting with chronic, verrucous skin lesions unresponsive to conventional therapies. Multimodal treatment combining oral antifungals, cryotherapy, and adjunctive topical 5-Fluorouracil demonstrates efficacy in managing refractory cases. Follow-up visits three and 6 months after treatment cessation showed sustained lesion clearance and no recurrence.

Indexed as

chromoblastomycosisdermatological treatmentfungal infectioninfectious dermatologytropical skin infection

Identifiers

PMID39355768
PMCPMC11442313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.